Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umeharu Ohto

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Acta Pharmaceutica Sinica. B|December 12, 2024
Targeting toll-like receptor 7 as a therapeutic development strategy for systemic lupus erythematosusMeng Wang, Hekai Chen, Tuan Zhang, et al.
Nature Communications|October 16, 2020
Structural analysis reveals TLR7 dynamics underlying antagonismShingo Tojo, Zhikuan Zhang, Hiroyuki Matsui, et al.
Nature Communications|July 17, 2021
Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonistsYi Yang, Adam Csakai, Shuangshuang Jiang, et al.
Journal of Medicinal Chemistry|September 6, 2014
Determinants of activity at human Toll-like receptors 7 and 8: quantitative structure-activity relationship (QSAR) of diverse heterocyclic scaffoldsEuna Yoo, Deepak B Salunke, Diptesh Sil, et al.
Nature Communications|February 5, 2015
Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseasesAtsuo Kanno, Natsuko Tanimura, Masayuki Ishizaki, et al.
Nature|May 17, 2022
Structure of the bile acid transporter and HBV receptor NTCPJinta Asami, Kanako Terakado Kimura, Yoko Fujita-Fujiharu, et al.
Nature Structural & Molecular Biology|January 17, 2024
Structural basis of hepatitis B virus receptor bindingJinta Asami, Jae-Hyun Park, Yayoi Nomura, et al.
Nature Communications|January 30, 2026
Multistep receptor binding of the hepatitis B virus preS1 domainChisa Kobayashi, Toru Ekimoto, Koji Ooka, et al.
The Journal of Biological Chemistry|July 30, 2017
Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complexNaoki Okamoto, Keisuke Mizote, Hiroe Honda, et al.
Science (New York, N.Y.)|September 29, 2012
Coagulation factor X activates innate immunity to human species C adenovirusKonstantin Doronin, Justin W Flatt, Nelson C Di Paolo, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Acta Pharmaceutica Sinica. B|December 12, 2024
Targeting toll-like receptor 7 as a therapeutic development strategy for systemic lupus erythematosusMeng Wang, Hekai Chen, Tuan Zhang, et al.
Nature Communications|October 16, 2020
Structural analysis reveals TLR7 dynamics underlying antagonismShingo Tojo, Zhikuan Zhang, Hiroyuki Matsui, et al.
Nature Communications|July 17, 2021
Tetrasubstituted imidazoles as incognito Toll-like receptor 8 a(nta)gonistsYi Yang, Adam Csakai, Shuangshuang Jiang, et al.
Journal of Medicinal Chemistry|September 6, 2014
Determinants of activity at human Toll-like receptors 7 and 8: quantitative structure-activity relationship (QSAR) of diverse heterocyclic scaffoldsEuna Yoo, Deepak B Salunke, Diptesh Sil, et al.
Nature Communications|February 5, 2015
Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseasesAtsuo Kanno, Natsuko Tanimura, Masayuki Ishizaki, et al.
Nature|May 17, 2022
Structure of the bile acid transporter and HBV receptor NTCPJinta Asami, Kanako Terakado Kimura, Yoko Fujita-Fujiharu, et al.
Nature Structural & Molecular Biology|January 17, 2024
Structural basis of hepatitis B virus receptor bindingJinta Asami, Jae-Hyun Park, Yayoi Nomura, et al.
Nature Communications|January 30, 2026
Multistep receptor binding of the hepatitis B virus preS1 domainChisa Kobayashi, Toru Ekimoto, Koji Ooka, et al.
The Journal of Biological Chemistry|July 30, 2017
Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complexNaoki Okamoto, Keisuke Mizote, Hiroe Honda, et al.
Science (New York, N.Y.)|September 29, 2012
Coagulation factor X activates innate immunity to human species C adenovirusKonstantin Doronin, Justin W Flatt, Nelson C Di Paolo, et al.
Pageof 9